An overview of the kallikrein gene families in humans and other species: Emerging candidate tumour markers

Clinical Biochemistry

Volumn 36, Issue 6, 2003, Pages 443-452

  Yousef, George M ^a,b   Diamandis, Eleftherios P ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Alzheimer's disease; Breast cancer; Cancer biomarkers; Chromosome 19; Hormonally regulated genes; Kallikrein; Kallikrein evolution; Ovarian cancer; Prostate cancer; Rodent kallikreins; Serine proteases; Tumor markers

Indexed keywords

DNA; KALLIKREIN; MESSENGER RNA; PLASMA KALLIKREIN; STEROID HORMONE; TISSUE KALLIKREIN; TUMOR MARKER;

ALZHEIMER DISEASE; BREAST; CANCER; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASE; CHROMOSOME; DOG; ENDOCRINE GLAND; ENDOMETRIUM; GENE CONTROL; GENE LOCATION; GENE STRUCTURE; HUMAN; MASTOMYS; MONKEY; MULTIGENE FAMILY; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROSTATE; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REVIEW; SALIVARY GLAND; TESTIS;

EID: 0043264142     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(03)00055-9     Document Type: Review

References (119)

1. Schultz R.M., Liebman M.N. Structure-function relationship in protein families. Devlin T.M. Textbook of biochemistry with clinical correlations. Fourth Edition:1997;1-2-116 Wiley-liss, Inc, New York.
2. Werle E. Zur kenntnis des haushalts des kallikreins. Biochem Z. 269:1934;415-434.
3. Bhoola K.D., Figueroa C.D., Worthy K. Bioregulation of kinins kallikreins, kininogens, and kininases . Pharmacol Rev. 44:1992;1-80.
4. Movat H.Z. The plasma kallikrein-kinin system and its interrelationship with other components of blood. Erdos E.G. Bradykinin, kallidin and kallikrein. 1979;1-89 Springer-Verlag, Berlin.
5. Richards R.I., Catanzaro D.F., Mason A.J., Morris B.J., Baxter J.D., Shine J. Mouse glandular kallikrein genes. Nucleotide sequence of cloned cDNA coding for a member of the kallikrein arginyl esteropeptidase group of serine proteases. J Biol Chem. 257:1982;2758-2761.
6. Deperthes D., Marceau F., Frenette G., Lazure C., Tremblay R.R., Dube J.Y. Human kallikrein hK2 has low kininogenase activity while prostate- specific antigen (hK3) has none. Biochim Biophys Acta. 1343:1997;102-106.
7. Evans B.A., Drinkwater C.C., Richards R.I. Mouse glandular kallikrein genes. Structure and partial sequence analysis of the kallikrein gene locus. J Biol Chem. 262:1987;8027-8034.
8. Wines D.R., Brady J.M., Pritchett D.B., Roberts J.L., MacDonald R.J. Organization and expression of the rat kallikrein gene family. J Biol Chem. 264:1989;7653-7662.
9. Murray S.R., Chao J., Lin F.K., Chao L. Kallikrein multigene families and the regulation of their expression. J Cardiovasc Pharmacol. 15:1990;S7-16.
10. Margolius H.S. Tissue kallikreins Structure, regulation, and participation in mammalian physiology and disease . Clin Rev Allergy Immunol. 16:1998;337-349.
11. Clements J. The molecular biology of the kallikreins and their roles in inflammation. Farmer S. The Kinin System. 1997;71-97 Academic Press, New York.
12. Meyer, W. Distribution of tissue kallikrein in the integumental blood vessel system of wild mammals. Cell Mol Biol (Noisy-le-grand) 2001;47 Online Pub:OL125-30.
13. van Leeuwen B.H., Evans B.A., Tregear G.W., Richards R.I. Mouse glandular kallikrein genes. Identification, structure, and expression of the renal kallikrein gene. J Biol Chem. 261:1986;5529-5535.
14. Mason A.J., Evans B.A., Cox D.R., Shine J., Richards R.I. Structure of mouse kallikrein gene family suggests a role in specific processing of biologically active peptides. Nature. 303:1983;300-307.
15. Evans B.A., Richards R.I. Genes for the alpha and gamma subunits of mouse nerve growth factor are contiguous. EMBO J. 4:1985;133-138.
16. Fahnestock M., Woo J.E., Lopez G.A., Snow J., Walz D.A., Arici M.J., et al. beta-NGF-endopeptidase structure and activity of a kallikrein encoded by the gene mGK-22 . Biochemistry. 30:1991;3443-3450.
17. Ullrich A., Gray A., Wood W.I., Hayflick J., Seeburg P.H. Isolation of a cDNA clone coding for the gamma-subunit of mouse nerve growth factor using a high-stringency selection procedure. Dna. 3:1984;387-392.
18. MacDonald R.J., Southard-Smith E.M., Kroon E. Disparate tissue-specific expression of members of the tissue kallikrein multigene family of the rat. J Biol Chem. 271:1996;13684-13690.
19. Southard-Smith M., Pierce J.C., MacDonald R.J. Physical mapping of the rat tissue kallikrein family in two gene clusters by analysis of P1 bacteriophage clones. Genomics. 22:1994;404-417.
20. Ashley P.L., MacDonald R.J. Tissue-specific expression of kallikrein-related genes in the rat. Biochemistry. 24:1985;4520-4527.
21. Xiong W., Chen L.M., Chao J. Purification and characterization of a kallikrein-like T-kininogenase. J Biol Chem. 265:1990;2822-2827.
22. Gerald W.L., Chao J., Chao L. Sex dimorphism and hormonal regulation of rat tissue kallikrein mRNA. Biochim Biophys Acta. 867:1986;16-23.
23. Fahnestock M. Characterization of kallikrein cDNAs from the African rodent Mastomys. DNA Cell Biol. 13:1994;293-300.
24. Lin F.K., Lin C.H., Chou C.C., Chen K., Lu H.S., Bacheller W., et al. Molecular cloning and sequence analysis of the monkey and human tissue kallikrein genes. Biochim Biophys Acta. 1173:1993;325-328.
25. Gauthier E.R., Chapdelaine P., Tremblay R.R., Dube J.Y. Characterization of rhesus monkey prostate specific antigen cDNA. Biochim Biophys Acta. 1174:1993;207-210.
26. Chapdelaine P., Gauthier E., Ho-Kim M.A., Bissonnette L., Tremblay R.R., Dube J.Y. Characterization and expression of the prostatic arginine esterase gene, a canine glandular kallikrein. DNA Cell Biol. 10:1991;49-59.
27. Fiedler F., Betz G., Hinz H., Lottspeich F., Raidoo D.M., Bhoola K.D. Not more than three tissue kallikreins identified from organs of the guinea pig. Biol Chem. 380:1999;63-73.
28. Karr J.F., Kantor J.A., Hand P.H., Eggensperger D.L., Schlom J. The presence of prostate-specific antigen-related genes in primates and the expression of recombinant human prostate-specific antigen in a transfected murine cell line. Cancer Res. 55:1995;2455-2462.
29. Fujimori H., Levison P.R., Schachter M. Purification and partial characterization of cat pancreatic and urinary kallikreins-comparison with other cat tissue kallikreins and related proteases. Adv Exp Med Biol. 198:(Pt A):1986;219-228.
30. Rittenhouse H.G., Finlay J.A., Mikolajczyk S.D., Partin A.W. Human Kallikrein 2 (hK2) and prostate-specific antigen (PSA) two closely related, but distinct, kallikreins in the prostate . Crit Rev Clin Lab Sci. 35:1998;275-368.
31. Asakai R., Davie E.W., Chung D.W. Organization of the gene for human factor XI. Biochemistry. 26:1987;7221-7228.
32. Watt K.W., Lee P.J., M'Timkulu T., Chan W.P., Loor R. Human prostate-specific antigen structural and functional similarity with serine proteases . Proc Natl Acad Sci U S A. 83:1986;3166-3170.
33. Lundwall A., Lilja H. Molecular cloning of human prostate specific antigen cDNA. FEBS Lett. 214:1987;317-322.
34. Schedlich L.J., Bennetts B.H., Morris B.J. Primary structure of a human glandular kallikrein gene. DNA. 6:1987;429-437.
35. Evans B.A., Yun Z.X., Close J.A., Tregear G.W., Kitamura N., Nakanishi S., et al. Structure and chromosomal localization of the human renal kallikrein gene. Biochemistry. 27:1988;3124-3129.
36. Riegman P.H., Vlietstra R.J., Suurmeijer L., Cleutjens C.B., Trapman J. Characterization of the human kallikrein locus. Genomics. 14:1992;6-11.
37. Yousef G.M., Obiezu C.V., Luo L.Y., Black M.H., Diamandis E.P. Prostase/KLK-L1 is a new member of the human kallikrein gene family, is expressed in prostate and breast tissues, and is hormonally regulated. Cancer Res. 59:1999;4252-4256.
38. Yousef G.M., Luo L.Y., Diamandis E.P. Identification of novel human kallikrein-like genes on chromosome 19q13.3-q13.4. Anticancer Res. 19:1999;2843-2852.
39. Yousef G.M., Diamandis E.P. The expanded human kallikrein gene family locus characterization and molecular cloning of a new member, KLK-L3 (KLK9) . Genomics. 65:2000;184-194.
40. Yousef G.M., Magklara A., Diamandis E.P. KLK12 is a novel serine protease and a new member of the human kallikrein gene family-differential expression in breast cancer. Genomics. 69:2000;331-341.
41. Yousef G.M., Chang A., Diamandis E.P. Identification and characterization of KLK-L4, a new kallikrein-like gene that appears to be down-regulated in breast cancer tissues. J Biol Chem. 275:2000;11891-11898.
42. Yousef G.M., Magklara A., Chang A., Jung K., Katsaros D., Diamandis E.P. Cloning of a new member of the human kallikrein gene family, KLK14, which is down-regulated in different malignancies. Cancer Res. 61:2001;3425-3431.
43. Yousef G.M., Scorilas A., Jung K., Ashworth L.K., Diamandis E.P. Molecular cloning of the human kallikrein 15 gene (KLK15). Up- regulation in prostate cancer. J Biol Chem. 276:2001;53-61.
44. Nelson P.S., Gan L., Ferguson C., Moss P., Gelinas R., Hood L., et al. Molecular cloning and characterization of prostase, an androgen- regulated serine protease with prostate-restricted expression. Proc Natl Acad Sci U S A. 96:1999;3114-3119.
45. Brattsand M., Egelrud T. Purification, molecular cloning, and expression of a human stratum corneum trypsin-like serine protease with possible function in desquamation. J Biol Chem. 274:1999;30033-30040.
46. Anisowicz A., Sotiropoulou G., Stenman G., Mok S.C., Sager R. A novel protease homolog differentially expressed in breast and ovarian cancer. Mol Med. 2:1996;624-636.
47. Yoshida S., Taniguchi M., Hirata A., Shiosaka S. Sequence analysis and expression of human neuropsin cDNA and gene. Gene. 213:1998;9-16.
48. Yoshida S., Taniguchi M., Suemoto T., Oka T., He X., Shiosaka S. cDNA cloning and expression of a novel serine protease, TLSP. Biochim Biophys Acta. 1399:1998;225-228.
49. Stephenson S.A., Verity K., Ashworth L.K., Clements J.A. Localization of a new prostate-specific antigen-related serine protease gene, KLK4, is evidence for an expanded human kallikrein gene family cluster on chromosome 19q13.3-13.4. J Biol Chem. 274:1999;23210-23214.
50. Diamandis E.P., Yousef G.M. Human tissue kallikreins a family of new cancer biomarkers . Clin Chem. 48:2002;1198-1205.
51. Yousef G.M., Diamandis E.P. The new human tissue kallikrein gene family structure, function, and association to disease . Endocr Rev. 22:2001;184-204.
52. Yousef G.M., Diamandis E.P. Human kallikreins common structural features, sequence analysis and evolution . Current Genomics. 4:2003;147-165.
53. Yousef G.M., Diamandis E.P. The human tissue kallikreins A new enzymatic cascade pathway? Biol Chem. 48:2002;1198-1205.
54. Bernett M.J., Blaber S.I., Scarisbrick I.A., Dhanarajan P., Thompson S.M., Blaber M. Crystal structure and biochemical characterization of human kallikrein 6 reveals that a trypsin-like kallikrein is expressed in the central nervous system. J Biol Chem. 277:2002;24562-24570.
55. Katz B.A., Liu B., Barnes M., Springman E.B. Crystal structure of recombinant human tissue kallikrein at 2.0 A resolution. Protein Sci. 7:1998;875-885.
56. Clements J., Hooper J., Dong Y., Harvey T. The expanded human kallikrein (KLK) gene family genomic organisation, tissue-specific expression and potential functions . Biol Chem. 382:2001;5-14.
57. Lovgren J., Valtonen-Andre C., Marsal K., Lilja H., Lundwall A. Measurement of prostate-specific antigen and human glandular kallikrein 2 in different body fluids. J Androl. 20:1999;348-355.
58. Hu J.C., Zhang C., Sun X., Yang Y., Cao X., Ryu O., et al. Characterization of the mouse and human PRSS17 genes, their relationship to other serine proteases, and the expression of PRSS17 in developing mouse incisors. Gene. 251:2000;1-8.
59. Backman A., Stranden P., Brattsand M., Hansson L., Egelrud T. Molecular cloning and tissue expression of the murine analog to human stratum corneum chymotryptic enzyme. J Invest Dermatol. 113:1999;152-155.
60. Yamanaka H., He X., Matsumoto K., Shiosaka S., Yoshida S. Protease M/neurosin mRNA is expressed in mature oligodendrocytes. Brain Res Mol Brain Res. 71:1999;217-224.
61. Scarisbrick I.A., Towner M.D., Isackson P.J. Nervous system-specific expression of a novel serine protease regulation in the adult rat spinal cord by excitotoxic injury . J Neurosci. 17:1997;8156-8168.
62. Chen Z.L., Yoshida S., Kato K., Momota Y., Suzuki J., Tanaka T., et al. Expression and activity-dependent changes of a novel limbic-serine protease gene in the hippocampus. J Neurosci. 15:1995;5088-5097.
63. Davies B.J., Pickard B.S., Steel M., Morris R.G., Lathe R. Serine proteases in rodent hippocampus. J Biol Chem. 273:1998;23004-23011.
64. Mitsui S., Okui A., Kominami K., Uemura H., Yamaguchi N. cDNA cloning and tissue-specific splicing variants of mouse hippostasin/TLSP (PRSS20). Biochim Biophys Acta. 1494:2000;206-210.
65. Olsson A.Y., Lundwall A. Organization and evolution of the glandular kallikrein locus in Mus musculus. Biochem Biophys Res Commun. 299:2002;305-311.
66. Yousef G.M., Chang A., Scorilas A., Diamandis E.P. Genomic organization of the human kallikrein gene family on chromosome 19q13.3-q13.4. Biochem Biophys Res Commun. 276:2000;125-133.
67. Lee M.S. Molecular clock calibrations and metazoan divergence dates. J Mol Evol. 49:1999;385-391.
68. Korkmaz K.S., Korkmaz C.G., Pretlow T.G., Saatcioglu F. Distinctly different gene structure of KLK4/KLK-L1/Prostase/ARM1 compared with other members of the kallikrein family Intracellular localization, alternative cDNA forms, and regulation by multiple hormones . DNA Cell Biol. 20:2001;435-445.
69. Harvey T.J., Hooper J.D., Myers S.A., Stephenson S.A., Ashworth L.K., Clements J.A. Tissue-specific expression patterns and fine mapping of the human kallikrein (KLK) locus on proximal 19q13.4. J Biol Chem. 275:2000;37397-37406.
70. Angata T., Varki A. Cloning, characterization and phylogenetic analysis of Siglec-9, a new member of the CD33-related group of Siglecs. Evidence for co-evolution with sialic acid synthesis pathways. J Biol Chem. 275:2000;22127-22135.
71. Das H.K., Jackson C.L., Miller D.A., Leff T., Breslow J.L. The human apolipoprotein C-II gene sequence contains a novel chromosome 19-specific minisatellite in its third intron. J Biol Chem. 262:1987;4787-4793.
72. Yousef G.M., Bharaj B.S., Yu H., Poulopoulos J., Diamandis E.P. Sequence analysis of the human kallikrein gene locus identifies a unique polymorphic minisatellite element. Biochem Biophys Res Commun. 285:2001;1321-1329.
73. Fitch D.H., Bailey W.J., Tagle D.A., Goodman M., Sieu L., Slightom J.L. Duplication of the gamma-globin gene mediated by L1 long interspersed repetitive elements in an early ancestor of simian primates. Proc Natl Acad Sci U S A. 88:1991;7396-7400.
74. Margolius H.S., Horwitz D., Pisano J.J., Keiser H.R. Urinary kallikrein excretion in hypertensive man. Relationships to sodium intake and sodium-retaining steroids. Circ Res. 35:1974;820-825.
75. Jaffa A.A., Chai K.X., Chao J., Chao L., Mayfield R.K. Effects of diabetes and insulin on expression of kallikrein and renin genes in the kidney. Kidney Int. 41:1992;789-795.
76. Sondell B., Dyberg P., Anneroth G.K., Ostman P.O., Egelrud T. Association between expression of stratum corneum chymotryptic enzyme and pathological keratinization in human oral mucosa. Acta Derm Venereol. 76:1996;177-181.
77. Ekholm E., Egelrud T. Stratum corneum chymotryptic enzyme in psoriasis. Arch Dermatol Res. 291:1999;195-200.
78. Akita H., Matsuyama T., Iso H., Sugita M., Yoshida S. Effects of oxidative stress on the expression of limbic-specific protease neuropsin and avoidance learning in mice. Brain Res. 769:1997;86-96.
79. Momota Y., Yoshida S., Ito J., Shibata M., Kato K., Sakurai K., et al. Blockade of neuropsin, a serine protease, ameliorates kindling epilepsy. Eur J Neurosci. 10:1998;760-764.
80. Kishi T., Kato M., Shimizu T., Kato K., Matsumoto K., Yoshida S., et al. Crystal structure of neuropsin, a hippocampal protease involved in kindling epileptogenesis. J Biol Chem. 274:1999;4220-4224.
81. Shimizu-Okabe C., Yousef G.M., Diamandis E.P., Yoshida S., Shiosaka S., Fahnestock M. Expression of the kallikrein gene family in normal and Alzheimer's disease brain. Neuroreport. 12:2001;2747-2751.
82. Little S.P., Dixon E.P., Norris F., Buckley W., Becker G.W., Johnson M., et al. Zyme, a novel and potentially amyloidogenic enzyme cDNA isolated from Alzheimer's disease brain. J Biol Chem. 272:1997;25135-25142.
83. Yamashiro K., Tsuruoka N., Kodama S., Tsujimoto M., Yamamura Y., Tanaka T., et al. Molecular cloning of a novel trypsin-like serine protease (neurosin) preferentially expressed in brain. Biochim Biophys Acta. 1350:1997;11-14.
84. Yousef G.M., Diamandis E.P. The new kallikrein-like gene, KLK-L2. Molecular characterization, mapping, tissue expression, and hormonal regulation. J Biol Chem. 274:1999;37511-37516.
85. Yousef G.M., Kishi T., Diamandis E.P. Role of kallikrein enzymes in the central nervous system. Clin Chim Acta. 329:2003;1-8.
86. Yousef G.M., Diamandis E.P. Expanded human tissue kallikrein family-novel potential cancer biomarkers. Tumor Biol. 23:2002;185-192.
87. Yousef G.M., Diamandis E.P. Kallikreins, steroid hormones and ovarian cancer is there a link? Minerva Endocrinol. 27:2002;157-166.
88. Diamandis E.P. Prostate-specific antigen-its usefulness in clinical medicine. Trends Endocrinol Metab. 9:1998;310-316.
89. Liu X.L., Wazer D.E., Watanabe K., Band V. Identification of a novel serine protease-like gene, the expression of which is down-regulated during breast cancer progression. Cancer Res. 56:1996;3371-3379.
90. Goyal J., Smith K.M., Cowan J.M., Wazer D.E., Lee S.W., Band V. The role for NES1 serine protease as a novel tumor suppressor. Cancer Res. 58:1998;4782-4786.
91. Underwood L.J., Tanimoto H., Wang Y., Shigemasa K., Parmley T.H., O'Brien T.J. Cloning of tumor-associated differentially expressed gene-14, a novel serine protease overexpressed by ovarian carcinoma. Cancer Res. 59:1999;4435-4439.
92. Magklara A., Scorilas A., Katsaros D., Massobrio M., Yousef G.M., Fracchioli S., et al. The human KLK8 (neuropsin/ovasin) gene Identification of two novel splice variants and its prognostic value in ovarian cancer . Clin Cancer Res. 7:2001;806-811.
93. Tanimoto H., Underwood L.J., Shigemasa K., Yan Yan M.S., Clarke J., Parmley T.H., et al. The stratum corneum chymotryptic enzyme that mediates shedding and desquamation of skin cells is highly overexpressed in ovarian tumor cells. Cancer. 86:1999;2074-2082.
94. Obiezu C.V., Scorilas A., Katsaros D., Massobrio M., Yousef G.M., Fracchioli S., et al. Higher human kallikrein gene 4 (klk4) expression indicates poor prognosis of ovarian cancer patients. Clin Cancer Res. 7:2001;2380-2386.
95. Kim H., Scorilas A., Katsaros D., Yousef G.M., Massobrio M., Fracchioli S., et al. Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer. Br J Cancer. 84:2001;643-650.
96. Dong Y., Kaushal A., Bui L., Chu S., Fuller P.J., Nicklin J., et al. Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas. Clin Cancer Res. 7:2001;2363-2371.
97. Yousef G.M., Kyriakopoulou L.G., Scorilas A., Fracchioli S., Ghiringhello B., Zarghooni M., et al. Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer A new independent and favorable prognostic marker . Cancer Res. 61:2001;7811-7818.
98. Yousef G.M., Scorilas A., Kyriakopoulou L.G., Rendl L., Diamandis M., Ponzone R., et al. Human kallikrein gene 5 (KLK5) expression by quantitative PCR An independent indicator of poor prognosis in breast cancer . Clin Chem. 48:2002;1241-1250.
99. Diamandis E.P., Yousef G.M., Soosaipillai A.R., Bunting P. Human kallikrein 6 (zyme/protease M/neurosin) a new serum biomarker of ovarian carcinoma . Clin Biochem. 33:2000;579-583.
100. Diamandis E.P., Yousef G.M., Soosaipillai A.R., Grass L., Porter A., Little S., et al. Immunofluorometric assay of human kallikrein 6 (zyme/protease M/neurosin) and preliminary clinical applications. Clin Biochem. 33:2000;369-375.
101. Luo L.Y., Katsaros D., Scorilas A., Fracchioli S., Piccinno R., Rigault de la Longrais I.A., et al. Prognostic value of human kallikrein 10 expression in epithelial ovarian carcinoma. Clin Cancer Res. 7:2001;2372-2379.
102. Luo L., Bunting P., Scorilas A., Diamandis E.P. Human kallikrein 10 a novel tumor marker for ovarian carcinoma? Clin Chim Acta. 306:2001;111-118.
103. Diamandis E.P., Okui A., Mitsui S., Luo L.Y., Soosaipillai A., Grass L., et al. Human kallikrein 11 A new biomarker of prostate and ovarian carcinoma . Cancer Res. 62:2002;295-300.
104. Wolf W.C., Evans D.M., Chao L., Chao J. A synthetic tissue kallikrein inhibitor suppresses cancer cell invasiveness. Am J Pathol. 159:2001;1797-1805.
105. Lundwall A. Characterization of the gene for prostate-specific antigen, a human glandular kallikrein. Biochem Biophys Res Commun. 161:1989;1151-1159.
106. Riegman P.H., Klaassen P., van der Korput J.A., Romijn J.C., Trapman J. Molecular cloning and characterization of novel prostate antigen cDNA's. Biochem Biophys Res Commun. 155:1988;181-188.
107. Riegman P.H., Vlietstra R.J., van der Korput J.A., Romijn J.C., Trapman J. Characterization of the prostate-specific antigen gene a novel human kallikrein-like gene . Biochem Biophys Res Commun. 159:1989;95-102.
108. Sutherland G.R., Baker E., Hyland V.J., Callen D.F., Close J.A., Tregear G.W., et al. Human prostate-specific antigen (APS) is a member of the glandular kallikrein gene family at 19q13. Cytogenet Cell Genet. 48:1988;205-207.
109. Yousef G.M., Luo L.Y., Scherer S.W., Sotiropoulou G., Diamandis E.P. Molecular characterization of Zyme/Protease M/Neurosin (PRSS9), a hormonally regulated kallikrein-like serine protease. Genomics. 62:1999;251-259.
110. Hansson L., Stromqvist M., Backman A., Wallbrandt P., Carlstein A., Egelrud T. Cloning, expression, and characterization of stratum corneum chymotryptic enzyme. A skin-specific human serine proteinase. J Biol Chem. 269:1994;19420-19426.
111. Yousef G.M., Scorilas A., Magklara A., Soosaipillai A., Diamandis E.P. The KLK7 (PRSS6) gene, encoding for the stratum corneum chymotryptic enzyme is a new member of the human kallikrein gene family-genomic characterization, mapping, tissue expression and hormonal regulation. Gene. 254:2000;119-128.
112. Luo L., Herbrick J.A., Scherer S.W., Beatty B., Squire J., Diamandis E.P. Structural characterization and mapping of the normal epithelial cell- specific 1 gene. Biochem Biophys Res Commun. 247:1998;580-586.
113. Yousef G.M., Scorilas A., Diamandis E.P. Genomic organization, mapping, tissue expression, and hormonal regulation of trypsin-like serine protease (TLSP PRSS20), a new member of the human kallikrein gene family. Genomics. 63:2000;88-96.
114. Magklara A., Scorilas A., Catalona W.J., Diamandis E.P. The combination of human glandular kallikrein and free prostate- specific antigen (PSA) enhances discrimination between prostate cancer and benign prostatic hyperplasia in patients with moderately increased total PSA. Clin Chem. 45:1999;1960-1966.
115. Yousef G.M., Scorilas A., Chang A., Rendl L., Diamandis M., Jung K., et al. Down-regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissues. Prostate. 51:2002;126-132.
116. Yousef G.M., Obiezu C., Jung K., Stephan C., Scorilas A., Diamandis E.P. Differetial expression of kallikrein gene 5 (KLK5) in cancerous and normal testicular tissues. Urology. 60:2002;714-718.
117. Tanimoto H., Underwood L.J., Shigemasa K., Parmley T.H., O'Brien T.J. Increased expression of protease M in ovarian tumors. Tumour Biol. 22:2001;11-18.
118. Yousef GM, Scorilas A, Nakamura T, Abd Ellatif M, Ponzone R, Biglia, N. The prognostic value of the human kallikrein gene 9 (KLK9) in breast cancer. Breast Cancer Res Treat 2003 (In Press).
119. Yousef G.M., Fracchioli S., Scorilas A., Borgono C.A., Iskander L., Puopolo M. Steroid hormone regulation and prognostic value of the human kallikrein gene 14 (KLK14) in ovarian cancer. Am J Clin Path. 119:2003;346-355.